BSE filing, NSE: KMCSHIL. Summary written from the filing by ALFA Finder's alert engine.
KMC Speciality Hospitals (India) Ltd: key numbers
- Share price
- ₹150.95
- Market cap
- ₹2,462 Cr
- Revenue (annual)
- ₹305.8 Cr
- Net profit (annual)
- ₹46.73 Cr
- P/E (TTM)
- 44.1×Sector 51.1×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from KMC Speciality Hospitals (India) Ltd
All →KMC Speciality Hospitals (India) Share Pledge
KMC Speciality Hospitals (India) Ltd submitted a revised disclosure under SEBI (SAST) Regulations regarding the encumbrance of shares by its promoter group to the BSE.
KMC Speciality Hospitals (India) Annual General Meeting
KMC Speciality Hospitals (India) Limited held its 43rd Annual General Meeting on September 28, 2026. The meeting transacted ordinary and special business as per the notice.
KMC Speciality Hospitals (India) Share Pledge
Promoter Sri Kauvery Medical Care (India) Ltd has created an encumbrance on 27,41,435 equity shares of KMC Speciality Hospitals (India) Ltd.
KMC Speciality Hospitals (India) Annual Report
KMC Speciality Hospitals (India) Limited has filed its Annual Report and notice for the 43rd Annual General Meeting scheduled for September 28, 2026.
KMC Speciality Hospitals (India) Annual General Meeting
KMC Speciality Hospitals (India) Ltd has scheduled its 43rd Annual General Meeting for September 28, 2026, via video conferencing to transact special business.
KMC Speciality Hospitals (India) Investor Presentation: Key Takeaways
KMC Speciality Hospitals (India) Ltd reported robust Q1 FY27 results with a 39% increase in Total Income and a 120% surge in PAT.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.